WHO ICTRP trial
A clinical trial to evaluate efficacy and safety of fixed dose combination of…
CTRI/2015/05/005767 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2015/05/005767 |
|---|---|
| Public title | A clinical trial to evaluate efficacy and safety of fixed dose combination of Losartan, amlodipine and hydrochlorothiazide in hypertensive subjects with inadequate response to dual drug therapy |
| Scientific title | EVALUATION OF EFFICACY AND SAFETY OF FIXED DOSE COMBINATION OF LOSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN THE TREATMENT OF ESSENTIAL HYPERTENSION: AN OPEN LABEL, MULTI-CENTRIC TRIAL |
| Primary sponsor | Sun Pharma Laboratories Limited SPLL |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: null- Patient having seated diastolic BP (SeDBP) 90 to 100 mmHg and seated systolic BP (SeSBP) 140 to 200 mmHg. |
| Interventions | Intervention1: Fixed dose combination of losartan (50mg), amlodipine (5mg) and hydrochlorothiazide (12.5mg): The recommended dosage is fixed dose combination of losartan (50mg), amlodipine (5mg) and hydrochlorothiazide (12.5mg) administered… |
| Registration date | Dec 5, 2015 |
| Target size | 300 |
| Secondary IDs | SP/IP-108/0613 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: